NCT06934070View on ClinicalTrials.gov

Predictive Value of Albumin - Bilirubin Score and CRP - Albumin - Lymphocyte Index for HCC Prognosis After Radical Resection

Active, not recruitingOBSERVATIONAL
Enrollment

287

Participants

Timeline

Start Date

April 3, 2025

Primary Completion Date

April 3, 2025

Study Completion Date

April 16, 2025

Conditions
Hepatocellular Carcinoma (HCC)Hepatocellular Carcinoma (HCC) Prognosis
Trial Locations (1)

330029

Jiangxi Cancer Hospital, Nanchang

All Listed Sponsors
lead

Qiang Xu

OTHER

NCT06934070 - Predictive Value of Albumin - Bilirubin Score and CRP - Albumin - Lymphocyte Index for HCC Prognosis After Radical Resection | Biotech Hunter | Biotech Hunter